1. Be the Change. Do Something.
Copyright © The Stutman Switalski Group LLC 2017

2. Copyright © The Stutman Switalski Group LLC 2017

3. Copyright © The Stutman Switalski Group LLC 2017

4. Copyright © The Stutman Switalski Group LLC 2017
OVERPRESCRIBING
People v. Cheng
UNDERPRESCRIBING
Bergman v. Chin
Copyright © The Stutman Switalski Group LLC 2017

5. Suggested Best Practices for Compliance Program:
Frequently monitor your statistical prescribing habits (6 months);
Keep independent log and copies of C2 prescriptions and verify against PDMP
Have a policy for random patient “Pill Counts”;
Observed UDS;
Have a plan for violations of PMC or CSA;
Refer violators to Addiction Medicine;
Consider alternative therapy;
Office visit every 30 days for CII patients.
Policy for verifying the validity of MRI, X-Rays;
Demand complete medical records prior to first visit*;
Document, document, document;
Align treatment with functional goals;
Pain Management Contracts (PMC) or Controlled Substance Agreements (CSA);
Regularly update PMC or CSA;
*Some only apply to Pain Management Physicians
Copyright © The Stutman Switalski Group LLC 2017

6. #1: PATIENT HISTORY! DEVELOP A PROTOCOL NON- DISCRIMINATORY
Copyright © The Stutman Switalski Group LLC 2017

7. Copyright © The Stutman Switalski Group LLC 2017

8. 2016 Journal of Addiction Medicine
October 6, 2016: Under-reporting of drug use among self-reported risky drug users:
Amphetamines 66%
Opiates 45%
Cocaine 14%
Marijuana 7%
Under-reporting associated with history of incarceration and older age (p<0.05)
Copyright © The Stutman Switalski Group LLC 2017

9. #2: URINE DRUG SCREENING
Copyright © The Stutman Switalski Group LLC 2017

10. #3: PDMP
#4:
PILL COUNTS
Copyright © The Stutman Switalski Group LLC 2017

11. Copyright © The Stutman Switalski Group LLC 2017

12. EROWID
Copyright © The Stutman Switalski Group LLC 2017